Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia
The purpose of this Notice of Funding Opportunity (NOFO) is to support research to enable rapid and accurate identification of emerging vector-borne and zoonotic threats in Indonesia by building upon the scientific and laboratory infrastructure established under two previously awarded NOFOs.
Indonesia
is a recognized “hotspot” for emerging pathogens.
It is the world’s fourth largest population, spread among nearly 1000 inhabited islands stretching 3,400 miles along the equator, making opportunities for an emerging pathogen to become epidemic in the absence of a reliable detection system high.
The arthropod-borne viruses (arboviruses) and Rickettsia (typhus and spotted fevers) are of particular concern because of the ease with which vectors can transfer these viruses between wildlife, humans and livestock.
Remarkably, little is known about these diseases in Indonesia or their potential for movement within and from the country.
For example, only two of 11 pathogenic arboviruses known to be found in neighboring Australia have been identified in Indonesia.
Although Indonesia is known historically to be endemic for murine typhus and scrub typhus, they are almost never diagnosed.
CDC began a highly successful effort to build Indonesian capacity to identify emerging vector-borne diseases in 201 1. This effort helped to (1) build and support a state-of-the-art molecular diagnostic laboratory at Jakarta; (2) conduct countrywide training in virological techniques and biosafety; and (3) pilot a large-scale acute febrile illness (AFI) surveillance network.
During the previous cooperative agreement (RFA-CK-15-001), Indonesian and CDC partners identified the first West Nile and Zika virus cases in Indonesia, conducted the first Zika seroprevalence study, and identified Rickettsia felis for the first time as a cause of fatal neurological disease.
Indonesia is a leader of the Global Health Security Agenda and the CDC mission supports Indonesia’s efforts to fulfill its Joint External Evaluation (JEE) goals; especially strengthening the national laboratory system and improving the ability of real-time surveillance in detecting emerging pathogens (WHO/OHE/201 6. 4, Indonesia JEE, November 2017).
Indonesia
is a recognized “hotspot” for emerging pathogens.
It is the world’s fourth largest population, spread among nearly 1000 inhabited islands stretching 3,400 miles along the equator, making opportunities for an emerging pathogen to become epidemic in the absence of a reliable detection system high.
The arthropod-borne viruses (arboviruses) and Rickettsia (typhus and spotted fevers) are of particular concern because of the ease with which vectors can transfer these viruses between wildlife, humans and livestock.
Remarkably, little is known about these diseases in Indonesia or their potential for movement within and from the country.
For example, only two of 11 pathogenic arboviruses known to be found in neighboring Australia have been identified in Indonesia.
Although Indonesia is known historically to be endemic for murine typhus and scrub typhus, they are almost never diagnosed.
CDC began a highly successful effort to build Indonesian capacity to identify emerging vector-borne diseases in 201 1. This effort helped to (1) build and support a state-of-the-art molecular diagnostic laboratory at Jakarta; (2) conduct countrywide training in virological techniques and biosafety; and (3) pilot a large-scale acute febrile illness (AFI) surveillance network.
During the previous cooperative agreement (RFA-CK-15-001), Indonesian and CDC partners identified the first West Nile and Zika virus cases in Indonesia, conducted the first Zika seroprevalence study, and identified Rickettsia felis for the first time as a cause of fatal neurological disease.
Indonesia is a leader of the Global Health Security Agenda and the CDC mission supports Indonesia’s efforts to fulfill its Joint External Evaluation (JEE) goals; especially strengthening the national laboratory system and improving the ability of real-time surveillance in detecting emerging pathogens (WHO/OHE/201 6. 4, Indonesia JEE, November 2017).
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $5,000,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $5,000,000
Who's Eligible
Obtain Full Opportunity Text:
ull grant announcement, including additional requirements and forms
Additional Information of Eligibility:
ALERT Asia Foundation/Eijkman Institute for Molecular Biology (EIMB) is eligible to apply for this NOFO.
Full Opportunity Web Address:
http://www.archives.gov/nhprc/announcement/partnership.html
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2019-10-19
Application Due Date:
Archive Date:
2020-02-13
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
